We are live on
!
Find out more
EA
Emerald Advisers Portfolio holdings
AUM
$3.16B
1-Year Est. Return
109.58%
This Fund
S&P 500
This Quarter
Est. Return
+6.36%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$1.94B
AUM Growth
-$6.24M
(-0.32%)
Cap. Flow
-$8.36M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
18.4%
Holding
264
New
14
Increased
88
Reduced
101
Closed
15
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$20.5M |
| 2 |
Celsius Holdings
CELH
|
+$20M |
| 3 |
AdaptHealth
AHCO
|
+$19.3M |
| 4 |
Northern Oil and Gas
NOG
|
+$18.9M |
| 5 |
Privia Health
PRVA
|
+$16.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$24.9M |
| 2 |
Avient
AVNT
|
+$21.7M |
| 3 |
Onto Innovation
ONTO
|
+$20M |
| 4 |
Alkermes
ALKS
|
+$19.3M |
| 5 |
Visteon
VC
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.67% |
| 2 | Industrials | 16.05% |
| 3 | Consumer Discretionary | 13.81% |
| 4 | Technology | 13.49% |
| 5 | Financials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Orrstown Financial Services
ORRF
$836M
| $49K | ﹤0.01% |
2,038
| – | – |
|
227
Anterix
ATEX
$1.83B
| $39K | ﹤0.01% |
1,100
| – | – |
|
228
American Tower
AMT
$77.7B
| $38K | ﹤0.01% |
175
| – | – |
|
229
Goldman Sachs
GS
$313B
| $34K | ﹤0.01% |
115
+1
| +0.9% | +$324 |
|
230
PENN Entertainment
PENN
$2.74B
| $33K | ﹤0.01% |
+1,200
| New | +$38.7K |
|
231
Salesforce
CRM
$134B
| $29K | ﹤0.01% |
200
| – | – |
|
232
Cisco
CSCO
$450B
| $29K | ﹤0.01% |
716
+6
| +0.8% | +$266 |
|
233
SoFi Technologies
SOFI
$21.1B
| $28K | ﹤0.01% |
5,800
| – | – |
|
234
Adobe
ADBE
$89.5B
| $22K | ﹤0.01% |
79
| – | – |
|
235
Intel
INTC
$466B
| $20K | ﹤0.01% |
772
| – | – |
|
236
Kinsale Capital Group
KNSL
$7.95B
| $20K | ﹤0.01% |
+79
| New | +$19.7K |
|
237
Hayward Holdings
HAYW
$3.13B
| $19K | ﹤0.01% |
2,103
-835,016
| -100% | -$9.82M |
|
238
Target
TGT
$62.1B
| $19K | ﹤0.01% |
130
| – | – |
|
239
ICU Medical
ICUI
$3.93B
| $17K | ﹤0.01% |
+115
| New | +$19.1K |
|
|
ANSS
240
DELISTED
Ansys
ANSS
| $14K | ﹤0.01% |
64
| – | – |
|
|
JSDA
241
DELISTED
JONES SODA CO
JSDA
| $13K | ﹤0.01% |
46,624
-27,500
| -37% | -$7.67K |
|
242
Allegiant Air
ALGT
$2.64B
| $9K | ﹤0.01% |
119
-67,707
| -100% | -$7M |
|
|
TWTR
243
DELISTED
Twitter, Inc.
TWTR
| $4K | ﹤0.01% |
100
| – | – |
|
244
GoodRx Holdings
GDRX
$1B
| $1K | ﹤0.01% |
310
| – | – |
|
|
EMAN
245
DELISTED
eMagin Corporation
EMAN
| $1K | ﹤0.01% |
1,000
| – | – |
|
246
Accenture
ACN
$89.9B
| – | – |
-1,143
| Closed | -$317K |
|
247
Adeia
ADEA
$2.86B
| $0 | ﹤0.01% |
15
| – | – |
|
248
Blackstone
BX
$104B
| – | – |
-2,473
| Closed | -$226K |
|
249
Citigroup
C
$222B
| $0 | ﹤0.01% |
6
| – | – |
|
|
CADE
250
DELISTED
Cadence Bank
CADE
| – | – |
-8,233
| Closed | -$193K |
|
Similar funds
FTUS
BFA
BP
CVA
DWP
GKWIM
BI
FAM
Emerald Advisers's Q3 2022 Portfolio in Review
As of Q3 2022, Emerald Advisers held 264 positions worth $1.94B, down 0.32% from $1.94B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Emerald Advisers's Q3 2022 filing shows 14 new, 88 increased, 101 reduced and 15 closed positions. Its largest new stake was Blueprint Medicines: 318,574 shares worth $21M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $24.9M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Emerald Advisers's largest Q3 2022 buy was Blueprint Medicines: 318,574 shares worth $21M.
- Emerald Advisers added most to AdaptHealth in Q3 2022, an estimated $19.3M increase.
- Emerald Advisers's biggest Q3 2022 reduction was Avient, cutting an estimated $21.7M.
- Emerald Advisers fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $24.9M.
- Emerald Advisers's ten largest holdings make up 18% of its $1.94B portfolio in Q3 2022.
- Emerald Advisers opened 14 new positions and closed 15 in Q3 2022.
- Emerald Advisers's portfolio value fell 0.32% quarter-over-quarter to $1.94B.
Based on Emerald Advisers's 13F filing for Q3 2022, filed 25 Oct 2022.